Key facts
- Notable investors include Heda Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Weikang Pingsheng
- ·The full record, as it builds
Funding rounds
No funding rounds for Weikang Pingsheng are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Weikang Pingsheng
Developer of Adiposome-based drug delivery system designed to improve drug efficiency. The company focuses on developing Adiposome-based Drug Delivery System (ADDS) utilizing nanotechnology that can be applied in small molecule innovative drugs and large molecule innovative drugs such as antibodies, peptides, nucleic acids, and tumor vaccines, providing advanced drug delivery solution for medical users.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Weikang Pingsheng doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Weikang Pingsheng shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Weikang Pingsheng in its N-PORT filings yet. We sweep new filings monthly.